Evidence map›Paper›PMID 16613895›Full record

ArticleBrain : a journal of neurology2006

Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech.

Keith A Josephs, Joseph R Duffy, Edyth A Strand, Jennifer L Whitwell, Kenneth F Layton, Joseph E Parisi, Mary F Hauser, Robert J Witte, Bradley F Boeve, David S Knopman and 3 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00545974 (A Prospective, Randomized, Multi-Center, Double-Blind, 26 Week, Placebo-Controlled Trial of Memantine), which is not on this map. Cited by 329 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
329citing papers in PubMed, 4 pooled it
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00545974 phase4completednot on this mapstarted 2007, after this paper: background citation

A Prospective, Randomized, Multi-Center, Double-Blind, 26 Week, Placebo-Controlled Trial of Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia

TypeinterventionalSponsorUniversity of California, San FranciscoRan2007 to 2012Enrolled81ConditionsFrontal Lobe Dementia, Frontotemporal Lobe Dementia, Semantic DementiaArmsmemantine, Placebo pill
3 · Its place in the literature

Who cites it

329 citing papers in PubMed, 4 syntheses or guidelines pooled it, 686 citations in OpenAlex.

  1. Which ante mortem clinical features predict progressive supranuclear palsy pathology?Movement disorders : official journal of the Movement Disorder Society · 2017
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Non-fluent agrammatic variant of primary progressive aphasia in a bilingual Mandarin/English speaker: a case report.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Word Count Matters: Features of Written Language Production in Progressive Apraxia of Speech with and without Agrammatism.Folia phoniatrica et logopaedica : official organ of the International Association of Logopedics and Phoniatrics (IALP) · 2025
    Article
  20. Article

269 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Keith A JosephsDepartment of Neurology, Division of Movement Disorders and Behavioral Neurology, Mayo Clinic, Rochester, MN 55905, USA.josephs.keith@mayo.edu
Joseph R Duffy
Edyth A Strand
Jennifer L Whitwell
Kenneth F Layton
Joseph E Parisi
Mary F Hauser
Robert J Witte
Bradley F Boeve
David S Knopman
Dennis W Dickson
Clifford R Jack
Ronald C Petersen
Mayo Clinic in Arizona · US

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI PETRUCELLI, LEONARD · 1999 to 2018
$36.9M
PREDICTING ALZHEIMERS DISEASE WITH MAGNETIC RESONANCER01AG011378 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R. · 1993 to 2017
$12.1M
Clinical Research Development Program (RMI)K12HD049078 · NICHD · MAYO CLINIC · PI GABRIEL, SHERINE E · 2004 to 2004
$1.1M
NIA NIH HHS P50 AG016574NIA NIH HHS P50 AG16574NIA NIH HHS R01 AG011378NIA NIH HHS R01 AG11378NIA NIH HHS U01 AG006786NIA NIH HHS U01 AG06786NICHD NIH HHS K12 HD049078NICHD NIH HHS K12-HD49078
6 · The paper itself

Abstract

Apraxia of speech (AOS) is a motor speech disorder characterized by slow speaking rate, abnormal prosody and distorted sound substitutions, additions, repetitions and prolongations, sometimes accompanied by groping, and trial and error articulatory movements. Although AOS is frequently subsumed under the heading of aphasia, and indeed most often co-occurs with aphasia, it can be the predominant or even the sole manifestation of a degenerative neurological disease. In this study we determine whether the clinical classifications of aphasia and AOS correlated with pathological diagnoses and specific biochemical and anatomical structural abnormalities. Seventeen cases with initial diagnoses of a degenerative aphasia or AOS were re-classified independently by two speech-language pathologists--blinded to pathological and biochemical findings--into one of five operationally defined categories of aphasia and AOS. Pathological diagnoses in the 17 cases were progressive supranuclear palsy in 6, corticobasal degeneration in 5, frontotemporal lobar degeneration with ubiquitin-only-immunoreactive changes in 5 and Pick's disease in 1. Magnetic resonance imaging analysis using voxel-based morphometry (VBM), and single photon emission tomography were completed, blinded to the clinical diagnoses, and clinicoimaging and clinicopathological associations were then sought. Interjudge clinical classification reliability was 87% (kappa = 0.8) for all evaluations. Eleven cases had evidence of AOS, of which all (100%) had a pathological diagnosis characterized by underlying tau biochemistry, while five of the other six cases without AOS did not have tau biochemistry (P = 0.001). A majority of the 17 cases had more than one yearly evaluation, demonstrating the evolution of the speech and language syndromes, as well as motor signs. VBM revealed the premotor and supplemental motor cortices to be the main cortical regions associated with AOS, while the anterior peri-sylvian region was associated with non-fluent aphasia. Refining the classification of the degenerative aphasias and AOS may be necessary to improve our understanding of the relationships among behavioural, pathological and imaging correlations.

Indexed as

AgedAphasiaApraxiasBrain MappingFemaleHumansLanguage TestsMagnetic Resonance ImagingMaleMiddle AgedMotor CortexMovement DisordersNeurodegenerative DiseasesSupranuclear Palsy, ProgressiveTomography, Emission-Computed, Single-Photon

Identifiers

PMID16613895
PMCPMC2748312
OpenAlexW2106279576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.